Treatment of results Sample Clauses

Treatment of results. (i) If Procedure 1 or 2 were employed in making concentration measurements, use a linear regression analysis with Equation 4 under para- graph (a)(2)(v)(B) of this section to cal- culate kh at 25 °C for each pH employed in the hydrolysis experiments. Cal- culate the coefficient of determination (R2) for each rate constant. Use Equa- tion 3 under paragraph (a)(2)(v)(B) of this section to calculate the hydrolysis half-life using kh.
AutoNDA by SimpleDocs
Treatment of results. (i) The molar absorption co- efficient e should be calculated for all absorbance maxima of the test sub- stance. The formula for this calcula- tion is: ε= A , c,i ×d where the quantities are as defined above (see Definitions and units).
Treatment of results. (i) Test compound (10 mg car- bon) is theoretically converted to 0.833 mmol CO2. Absorbed CO2 precipitates as BaCO3 from Ba(OH)2, causing a re- duction in alkalinity by the equivalent of 16.67 mL of 0.1 N HCl for complete conversion of the test compound car- bon to CO2. Therefore, the percent the- oretical CO2 evolved from the test com- pound is calculated at any sampling time from the formula: Percent CO2 evolution=[(TF¥CF)/16.67] 100 (for 10 mg/L test compound car- bon) where: TF= mL 0.1 N HCl required to titrate Ba(OH)2 samples from the test flask CF= mL 0.1 N HCl required to titrate Ba(OH)2 samples from the control flask.
Treatment of results. D a t a s h a ll be s u mm a r ized i n t a b u l a r fo r m .
Treatment of results. ( i) If P r oced ur e 1 o r 2 we r e e m plo y ed i n m a k i n g co n ce n t r a t io n m e a s ur e m e n t s, u se a li n e a r r eg r essio n a n a l y s i s wi t h E q u a t io n 4 un de r p a r a- g r a p h ( a)(2)(v)(B) of t h i s sec t io n t o c a l- c u l a t e kh a t 25 °C fo r e a c h p H e m plo y ed i n t h e hy d r ol y s i s expe r i m e n t s. Ca l- c u l a t e t h e coefficie n t of de t e r m i n a t io n ( R2) fo r e a c h r a t e co n s t a n t . Use E q u a- t io n 3 un de r p a r a g r a p h ( a)(2)(v)(B) of t h i s sec t io n t o c a lc u l a t e t h e hy d r ol y s i s h a lf- life u s i n g kh.
Treatment of results. ( i) T h e m ol a r a bso r p t io n co- efficie n t e s h o u ld be c a lc u l a t ed fo r a ll a bso r b a n ce m a xi m a of t h e t es t s u b- s t a n ce. T h e fo r m u l a fo r t h i s c a lc u l a- t io n i s: ε = A , c,i ×d w h e r e t h e q u a n t i t ies a r e a s defi n ed a bove ( see Defi n i t io n s a n d un i t s).
Treatment of results. ( i) T es t co m po un d (10 m g c a r - bo n) i s t h eo r e t ic a ll y co n ve r t ed t o 0.833 mm ol CO 2. Abso r bed CO2 p r ecipi t a t es a s B a CO3 f r o m B a(OH)2, c a u s i n g a r e- d u c t io n i n a l k a li n i t y b y t h e eq u iv a le n t of 16.67 m L of 0.1 N HCl fo r co m ple t e co n ve r s io n of t h e t es t co m po un d c a r - bo n t o CO2. T h e r efo r e, t h e pe r ce n t t h e- o r e t ic a l CO2 evolved f r o m t h e t es t co m - po un d i s c a lc u l a t ed a t a ny s a m pli n g t i m e f r o m t h e fo r m u l a : P e r ce n t CO2 evol u t io n =[( T F–C F )/16.67] 100 (fo r 10 m g/L t es t co m po un d c a r bo n) w h e r e: T F= m L 0.1 N HCl r eq u i r ed t o t i t r a t e B a(OH)2 s a m ples f r o m t h e t es t fl a s k C F= m L 0.1 N HCl r eq u i r ed t o t i t r a t e B a(OH)2 s a m ples f r o m t h e co n t r ol fl a s k . ( ii) T h e c u m u l a t ive pe r ce n t CO2 evo- l u t io n a t a ny s a m ple t i m e i s c a lc u l a t ed a s t h e s u mm a t io n of t h e pe r ce n t CO2 evolved a t a ll s a m ple poi n t s of t h e t es t . ( iii) T h e pe r ce n t DOC dis a ppe a r a n ce f r o m t h e t es t co m po un d i s c a lc u l a t ed f r o m t h e followi n g eq u a t io n: P e r ce n t DOC R e m ov a l=[1¥( D T Fx¥ DC Fx)/ ( D T Fo¥ DC Fo)] 100 w h e r e: D T F= Dissolved o r g a n ic c a r bo n f r o m t es t fl a s k DC F= Dissolved o r g a n ic c a r bo n f r o m co n t r ol fl a s k o= D a y ze r o m e a s ur e m e n t s x= D a y of m e a s ur e m e n t s d ur i n g t es t .
AutoNDA by SimpleDocs
Treatment of results. (i) Test compound (10 mg car- where: DTF= Dissolved organic carbon from test flask DCF= Dissolved organic carbon from control flask o= Day zero measurements x= Day of measurements during test.
Treatment of results. (i) The molar absorption co- efficient e should be calculated for all

Related to Treatment of results

  • Treatment The Asset Representations Reviewer agrees to hold and treat Confidential Information given to it under this Agreement in confidence and under the terms and conditions of this Section 4.08, and will implement and maintain safeguards to further assure the confidentiality of the Confidential Information. The Confidential Information will not, without the prior consent of the Issuer and the Servicer, be disclosed or used by the Asset Representations Reviewer, or its officers, directors, employees, agents, representatives or affiliates, including legal counsel (collectively, the “Information Recipients”) other than for the purposes of performing Reviews of Review Receivables or performing its obligations under this Agreement. The Asset Representations Reviewer agrees that it will not, and will cause its Affiliates to not (i) purchase or sell securities issued by the Seller or its Affiliates or special purpose entities on the basis of Confidential Information or (ii) use the Confidential Information for the preparation of research reports, newsletters or other publications or similar communications.

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

Time is Money Join Law Insider Premium to draft better contracts faster.